Friday, December 5, 2025
Search

SuRo Capital Corp. And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

SuRo Capital Corp.  And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - SuRo Capital Corp. (SSSS), DENTSPLY SIRONA (XRAY), Bank OZK (OZK) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. SuRo Capital Corp. (SSSS)

47.1% sales growth and 68.05% return on equity

Sutter Rock Capital Corp. is specializing in growth capital, B round and beyond, emerging growth, and pre-IPO investments in late stage venture-backed private companies.

SuRo Capital Corp.'s sales growth this year is anticipated to be 59% and a negative 0% for next year.

Year-on-year quarterly revenue growth grew by 15.7%, now sitting on 1.86M for the twelve trailing months.

Volume

Today's last reported volume for SuRo Capital Corp. is 497443 which is 15.86% above its average volume of 429345.

SuRo Capital Corp.'s sales growth for the next quarter is 47.1%. The company's growth estimates for the ongoing quarter and the next is 89.1% and negative -15.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 68.05%.

Volatility

SuRo Capital Corp.'s last day, last week, and last month's current volatility was 0.78%, 3.28%, and 1.75%, respectively.

SuRo Capital Corp.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.40% (day), 4.64% (last week), and 3.10% (last month), respectively.

SuRo Capital Corp.'s Stock Yearly Top and Bottom Value

SuRo Capital Corp.'s stock is valued at $14.23 at 16:23 EST, way below its 52-week high of $16.25 and way higher than its 52-week low of $8.03.

SuRo Capital Corp.'s Moving Average

SuRo Capital Corp.'s value is higher than its 50-day moving average of $13.11 and above its 200-day moving average of $13.84.

2. DENTSPLY SIRONA (XRAY)

22% sales growth and 3.62% return on equity

DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide.

DENTSPLY SIRONA's sales growth this year is expected to be 27.1% and 5.2% for next year.

Year-on-year quarterly revenue growth grew by 17.5%, now sitting on 3.5B for the twelve trailing months.

Volume

Today's last reported volume for DENTSPLY SIRONA is 5180740 which is 308.39% above its average volume of 1268570.

DENTSPLY SIRONA's sales growth for the next quarter is 22%. The company's growth estimates for the current quarter and the next is 461.1% and negative -1.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.62%.

Volatility

DENTSPLY SIRONA's last day, last week, and last month's current volatility was 2.10%, 1.00%, and 1.10%, respectively.

DENTSPLY SIRONA's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.00% (day), 1.81% (last week), and 1.86% (last month), respectively.

DENTSPLY SIRONA's Stock Yearly Top and Bottom Value

DENTSPLY SIRONA's stock is valued at $59.75 at 16:23 EST, way under its 52-week high of $69.54 and way higher than its 52-week low of $41.52.

DENTSPLY SIRONA's Moving Average

DENTSPLY SIRONA's value is under its 50-day moving average of $63.63 and below its 200-day moving average of $62.56.

Previous days news about DENTSPLY SIRONA(XRAY)

According to Business Insider on Monday, 9 August, "3M Co., Danaher Corp., DENTSPLY SIRONA Inc., Ivoclar Vivadent AG, Midmark Corp., Nouvag AG, Planmeca Group, Stratasys Ltd., Straumann Holding AG, and W and H are some of the major market participants.", "Some of the major vendors of the dental diagnostics and surgical equipment marketinclude 3M Co., Danaher Corp., DENTSPLY SIRONA Inc., Ivoclar Vivadent AG, Midmark Corp., Nouvag AG, Planmeca Group, Stratasys Ltd., Straumann Holding AG, and W and H. To help businesses improve their market position, Technavio's report provides a detailed analysis of vendors operating in the market."

3. Bank OZK (OZK)

6.2% sales growth and 12.27% return on equity

Bank OZK provides various retail and commercial banking services.

Bank OZK's sales growth this year is anticipated to be 5.1% and 1.6% for next year.

Year-on-year quarterly revenue growth grew by 80.2%, now sitting on 1.1B for the twelve trailing months.

Volume

Today's last reported volume for Bank OZK is 488948 which is 18.37% below its average volume of 598998.

Bank OZK's sales growth for the next quarter is 6.2%. The company's growth estimates for the ongoing quarter and the next is 135.9% and 4.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.27%.

Volatility

Bank OZK's last day, last week, and last month's current volatility was 3.70%, 1.87%, and 1.99%, respectively.

Bank OZK's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.01% (day), 3.22% (last week), and 3.18% (last month), respectively.

Bank OZK's Stock Yearly Top and Bottom Value

Bank OZK's stock is valued at $43.16 at 16:23 EST, under its 52-week high of $45.83 and way higher than its 52-week low of $20.10.

Bank OZK's Moving Average

Bank OZK's worth is above its 50-day moving average of $41.14 and above its 200-day moving average of $41.10.

4. FTI Consulting (FCN)

5.9% sales growth and 15.7% return on equity

FTI Consulting, Inc. provides business advisory services to manage change, mitigate risk, and resolve disputes worldwide.

FTI Consulting's sales growth this year is expected to be 7.6% and 6.8% for next year.

Year-on-year quarterly revenue growth grew by 17%, now sitting on 2.65B for the twelve trailing months.

Volume

Today's last reported volume for FTI Consulting is 145222 which is 37.02% below its average volume of 230590.

FTI Consulting's sales growth for the next quarter is 5.9%. The company's growth estimates for the present quarter and the next is 15.2% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.7%.

Volatility

FTI Consulting's last day, last week, and last month's current volatility was 0.19%, 0.67%, and 0.78%, respectively.

FTI Consulting's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.42% (day), 1.78% (last week), and 1.70% (last month), respectively.

FTI Consulting's Stock Yearly Top and Bottom Value

FTI Consulting's stock is valued at $144.43 at 16:23 EST, under its 52-week high of $147.38 and way higher than its 52-week low of $94.87.

FTI Consulting's Moving Average

FTI Consulting's worth is above its 50-day moving average of $138.18 and above its 200-day moving average of $132.75.